Pharmacology Practice Test — Questions and Answers
Question 1: In a quantal dose-response curve, the ED50 represents the dose that produces the desired effect in what percentage of the population?
- 25%
- 100%
- 50% (Correct answer)
- 75%
Correct answer: 50%
ED50 in a quantal dose-response relationship is the dose producing the specified effect (e.g., analgesia) in 50% of the test population.
Question 2: Which of the following conditions would most likely INCREASE the free fraction of a highly protein-bound drug?
- Increased plasma volume from IV fluids
- Normal renal function
- High dietary protein intake
- Hypoalbuminemia from liver cirrhosis (Correct answer)
Correct answer: Hypoalbuminemia from liver cirrhosis
Hypoalbuminemia reduces available binding sites, increasing the unbound (free) drug fraction and risk of toxicity.
Question 3: A patient with schizophrenia is switched from oral risperidone to an injectable long-acting formulation. What is the primary advantage of this formulation change?
- Higher peak plasma concentrations improving antipsychotic efficacy
- Improved adherence by eliminating the need for daily oral dosing (Correct answer)
- Avoidance of first-pass hepatic metabolism reducing drug interactions
- Fewer extrapyramidal side effects due to slower receptor occupancy
Correct answer: Improved adherence by eliminating the need for daily oral dosing
Long-acting injectable antipsychotics eliminate the need for daily medication, dramatically improving adherence in patients who struggle to take oral medications consistently.
Question 4: Which of the following describes the mechanism of a non-competitive antagonist?
- It binds to an allosteric site on the receptor, changing the receptor's conformation and preventing agonist activation. (Correct answer)
- It produces an effect opposite to that of the agonist by binding to the same receptor.
- It binds to the same site as the agonist, and its effect can be overcome by increasing the agonist concentration.
- It enhances the binding affinity of the agonist for the receptor, leading to an exaggerated response.
Correct answer: It binds to an allosteric site on the receptor, changing the receptor's conformation and preventing agonist activation.
A non-competitive antagonist binds to a site on the receptor that is different from the agonist's binding site (an allosteric site). [2, 9] This binding causes a conformational change in the receptor, which reduces the ability of the agonist to bind or activate the receptor, thereby decreasing the maximal possible effect (Emax). This effect cannot be overcome by simply increasing the concentration of the agonist. [8]
Question 5: A surgeon administers neostigmine to a patient at the end of a procedure to reverse the effects of a non-depolarizing neuromuscular blocker. What is the mechanism of action for neostigmine?
- It acts as a competitive antagonist at the same receptor as the neuromuscular blocker.
- It directly stimulates nicotinic receptors at the neuromuscular junction.
- It inhibits the breakdown of acetylcholine by acetylcholinesterase. (Correct answer)
- It blocks the reuptake of acetylcholine into the presynaptic terminal.
Correct answer: It inhibits the breakdown of acetylcholine by acetylcholinesterase.
Neostigmine is a reversible acetylcholinesterase inhibitor. By inhibiting the enzyme acetylcholinesterase, it prevents the breakdown of acetylcholine in the synaptic cleft. This increases the concentration and duration of action of acetylcholine at the neuromuscular junction, allowing it to outcompete the non-depolarizing blocker and restore neuromuscular transmission.
Question 6: Which PK/PD parameter best correlates with the efficacy of beta-lactam antibiotics?
- Trough level
- Time above MIC (%T>MIC) (Correct answer)
- AUC/MIC ratio
- Cmax/MIC ratio
Correct answer: Time above MIC (%T>MIC)
Beta-lactams exhibit time-dependent killing; efficacy is best predicted by the percentage of the dosing interval that free drug concentrations remain above the MIC.
Question 7: Furosemide is a loop diuretic used in acute pulmonary edema. Its rapid clinical effect is achieved by:
- Inhibiting carbonic anhydrase
- Osmotic diuresis in the proximal tubule
- Blocking aldosterone receptors
- Inhibiting Na+/K+/2Cl- cotransporter in the loop of Henle (Correct answer)
Correct answer: Inhibiting Na+/K+/2Cl- cotransporter in the loop of Henle
Furosemide inhibits the NKCC2 transporter in the thick ascending loop of Henle, producing a rapid, profound diuresis.
Question 8: Which mechanism best explains how fluoroquinolones kill bacteria?
- Inhibition of cell wall synthesis
- Inhibition of DNA gyrase and topoisomerase IV (Correct answer)
- Disruption of cell membrane integrity
- Inhibition of 50S ribosomal subunit
Correct answer: Inhibition of DNA gyrase and topoisomerase IV
Fluoroquinolones inhibit DNA gyrase (topoisomerase II) in gram-negative bacteria and topoisomerase IV in gram-positive bacteria, preventing DNA replication and repair.
Question 9: Which antibiotic inhibits bacterial cell wall synthesis by binding to penicillin-binding protein 2a (PBP2a), making it effective against MRSA?
- Linezolid
- Vancomycin
- Daptomycin
- Ceftaroline (Correct answer)
Correct answer: Ceftaroline
Ceftaroline is the only FDA-approved cephalosporin with anti-MRSA activity because it has high affinity for PBP2a, the altered target that confers methicillin resistance.
Question 10: Which muscarinic receptor subtype is primarily responsible for the decrease in heart rate caused by vagal stimulation?
- M1
- M4
- M3
- M2 (Correct answer)
Correct answer: M2
M2 receptors in the sinoatrial node mediate the negative chronotropic effect of acetylcholine released by vagal stimulation.
Question 11: A loading dose is used clinically to:
- Rapidly achieve therapeutic plasma concentrations (Correct answer)
- Reduce the half-life of a drug
- Decrease volume of distribution
- Prolong steady-state duration
Correct answer: Rapidly achieve therapeutic plasma concentrations
A loading dose achieves therapeutic concentrations quickly without waiting for 4-5 half-lives of accumulation.
Question 12: Which mechanism best explains the action of aspirin as an irreversible inhibitor of cyclooxygenase?
- Chelation of a cofactor metal ion
- Covalent acetylation of a serine residue (Correct answer)
- Allosteric distortion of the enzyme
- Competitive active-site blockade
Correct answer: Covalent acetylation of a serine residue
Aspirin covalently acetylates Ser530 of COX-1 and Ser516 of COX-2, permanently inactivating the enzyme for its lifespan.
Question 13: A patient with a penicillin allergy requires treatment for MRSA bacteremia. Which antibiotic is the drug of choice?
- Ampicillin
- Nafcillin
- Vancomycin (Correct answer)
- Oxacillin
Correct answer: Vancomycin
Vancomycin is the first-line agent for MRSA infections and is a safe alternative for penicillin-allergic patients since it belongs to a different drug class.
Question 14: Milrinone is used in acute heart failure. Its mechanism differs from catecholamines because it:
- Stimulates beta-1 receptors to increase contractility
- Inhibits phosphodiesterase-3, preventing cAMP degradation without acting on adrenergic receptors (Correct answer)
- Blocks alpha-1 receptors to reduce afterload exclusively
- Activates adenylyl cyclase directly by binding beta receptors
Correct answer: Inhibits phosphodiesterase-3, preventing cAMP degradation without acting on adrenergic receptors
Milrinone is a PDE-3 inhibitor that prevents cAMP breakdown, increasing contractility and causing vasodilation independently of adrenergic receptor stimulation.
Question 15: Rivaroxaban is a direct oral anticoagulant (DOAC) that inhibits which clotting factor?
- Factor Xa (Correct answer)
- Factor IIa (thrombin)
- Factor VIIa
- Factor IXa
Correct answer: Factor Xa
Rivaroxaban directly inhibits Factor Xa, blocking the conversion of prothrombin to thrombin at the convergence of intrinsic and extrinsic pathways.
Question 16: A patient brought to the emergency department after a suspected overdose is unconscious with significant respiratory depression. An empty bottle of lorazepam is found at the scene. Which of the following medications should be administered to reverse the effects of the benzodiazepine?
- Naloxone
- N-acetylcysteine
- Flumazenil (Correct answer)
- Protamine sulfate
Correct answer: Flumazenil
Flumazenil is a competitive antagonist at the benzodiazepine binding site on the GABA-A receptor. It competitively displaces benzodiazepines like lorazepam from the receptor, thereby reversing their sedative and respiratory depressant effects. Naloxone is an opioid antagonist, N-acetylcysteine is the antidote for acetaminophen overdose, and protamine sulfate reverses heparin.
Question 17: Which atypical antipsychotic has the highest risk of metabolic syndrome, including weight gain and diabetes?
- Lurasidone
- Aripiprazole
- Olanzapine (Correct answer)
- Ziprasidone
Correct answer: Olanzapine
Olanzapine carries the highest risk of metabolic side effects among atypical antipsychotics, including significant weight gain, dyslipidemia, and new-onset diabetes.
Question 18: Which antibiotic is the treatment of choice for Lyme disease caused by Borrelia burgdorferi in adults?
- Ciprofloxacin
- Azithromycin
- Penicillin G
- Doxycycline (Correct answer)
Correct answer: Doxycycline
Doxycycline is first-line treatment for early Lyme disease in adults and is also effective against early disseminated Lyme disease without neurologic involvement.
Question 19: A patient taking clozapine develops a fever, sore throat, and absolute neutrophil count of 400/mmÂł. What is the immediate action?
- Continue clozapine and start prophylactic antibiotics
- Switch to olanzapine and monitor weekly
- Reduce the clozapine dose by 50% and recheck ANC in 3 days
- Permanently discontinue clozapine and notify the registry (Correct answer)
Correct answer: Permanently discontinue clozapine and notify the registry
ANC below 500/mmÂł indicates severe agranulocytosis; clozapine must be permanently discontinued and the REMS registry notified immediately.
Question 20: A patient taking rifampin for tuberculosis reports that their oral contraceptives have become less effective. The most likely explanation is:
- Rifampin induces CYP450 enzymes, accelerating contraceptive metabolism (Correct answer)
- Rifampin inhibits CYP450 enzymes
- Rifampin kills normal vaginal flora
- Rifampin directly antagonizes estrogen receptors
Correct answer: Rifampin induces CYP450 enzymes, accelerating contraceptive metabolism
Rifampin is a potent CYP450 inducer that increases hepatic metabolism of estrogens and progestins, significantly reducing plasma levels of oral contraceptives.
Question 21: A patient on warfarin begins taking amiodarone. What INR adjustment is expected?
- No change; amiodarone does not interact with warfarin
- INR will increase; reduce warfarin dose (Correct answer)
- INR will decrease; increase warfarin dose
- INR will decrease; switch to a DOAC
Correct answer: INR will increase; reduce warfarin dose
Amiodarone inhibits CYP2C9, reducing warfarin metabolism and raising INR, so the warfarin dose must be reduced.
Question 22: A patient is diagnosed with VRE (vancomycin-resistant Enterococcus). Which antibiotic is approved for treating VRE infections?
- Daptomycin
- Tigecycline
- Ceftaroline
- Linezolid (Correct answer)
Correct answer: Linezolid
Linezolid (an oxazolidinone) is FDA-approved for treatment of VRE faecium infections and is active regardless of vancomycin resistance.
Question 23: Carbidopa is combined with levodopa in Parkinson's treatment primarily to:
- Inhibit peripheral DOPA decarboxylase, reducing peripheral dopamine conversion (Correct answer)
- Prevent levodopa degradation by MAO-B in the CNS
- Block COMT to extend levodopa's half-life systemically
- Enhance levodopa's effect on D2 receptors in the basal ganglia
Correct answer: Inhibit peripheral DOPA decarboxylase, reducing peripheral dopamine conversion
Carbidopa inhibits peripheral DOPA decarboxylase, preventing levodopa conversion to dopamine outside the CNS and reducing peripheral side effects while increasing CNS availability.
Question 24: A patient on warfarin starts metronidazole for C. difficile. What is the expected drug interaction?
- Increased INR due to CYP2C9 inhibition by metronidazole (Correct answer)
- No clinically significant interaction
- Decreased warfarin levels due to CYP induction
- Decreased metronidazole efficacy
Correct answer: Increased INR due to CYP2C9 inhibition by metronidazole
Metronidazole inhibits CYP2C9, reducing warfarin metabolism and increasing INR, raising the risk of bleeding.
Question 25: Dabigatran (a direct thrombin inhibitor) differs from warfarin in that it:
- Requires routine INR monitoring
- Is metabolized primarily by CYP2C9
- Has a specific reversal agent (idarucizumab) (Correct answer)
- Inhibits both intrinsic and extrinsic coagulation pathways equally
Correct answer: Has a specific reversal agent (idarucizumab)
Dabigatran can be rapidly reversed by idarucizumab (Praxbind), a monoclonal antibody fragment that binds dabigatran with high affinity, unlike warfarin's reversal with vitamin K/FFP.
Question 26: A patient on linezolid for VRE infection is given serotonergic medications. What potentially fatal adverse interaction must be monitored?
- Serotonin syndrome (Correct answer)
- Gray baby syndrome
- Neuroleptic malignant syndrome
- QT prolongation
Correct answer: Serotonin syndrome
Linezolid weakly inhibits monoamine oxidase (MAO), and when combined with serotonergic drugs (SSRIs, SNRIs, meperidine), can precipitate potentially fatal serotonin syndrome.
Question 27: Which cellular mechanism underlies the pharmacodynamic action of statins?
- Competitive inhibition of HMG-CoA reductase (Correct answer)
- G-protein–coupled inhibition of cholesterol absorption
- Allosteric activation of LDL receptors
- Irreversible blockade of bile acid transporters
Correct answer: Competitive inhibition of HMG-CoA reductase
Statins competitively inhibit HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, reducing intracellular cholesterol and upregulating hepatic LDL receptors.
Question 28: A patient undergoing surgery with sevoflurane and succinylcholine develops sudden tachycardia, muscle rigidity, and a rapid increase in body temperature. Which of the following intravenous agents is the definitive treatment for this life-threatening condition?
- Sodium Bicarbonate
- Dantrolene (Correct answer)
- Lorazepam
- Labetalol
Correct answer: Dantrolene
This patient is experiencing malignant hyperthermia (MH), a rare but severe reaction to volatile anesthetics (like sevoflurane) and depolarizing muscle relaxants (succinylcholine). Dantrolene is the specific antidote for MH. It works by binding to the ryanodine receptor (RyR1) in skeletal muscle, inhibiting the release of calcium from the sarcoplasmic reticulum and thereby resolving the hypermetabolic state and muscle rigidity.
Question 29: A drug has a very large apparent volume of distribution (Vd) of 400 L in a 70 kg adult. What does this indicate about the drug's distribution characteristics?
- It is largely confined to the intravascular space.
- It is highly bound to plasma proteins.
- It is a large molecule that cannot easily cross cell membranes.
- It is extensively distributed into tissues outside the plasma. (Correct answer)
Correct answer: It is extensively distributed into tissues outside the plasma.
The apparent volume of distribution (Vd) is a theoretical volume that relates the amount of drug in the body to its concentration in the plasma. A large Vd (significantly exceeding total body water of ~42 L) indicates that the drug is not confined to the plasma and has extensively distributed into extravascular tissues and fluids. This is often a characteristic of lipophilic drugs that readily cross cell membranes.
Question 30: Captopril is the prototype of which antihypertensive drug class?
- ACE inhibitors (Correct answer)
- Direct renin inhibitors
- Angiotensin receptor blockers (ARBs)
- Beta-blockers
Correct answer: ACE inhibitors
Captopril is the prototype ACE inhibitor, blocking conversion of angiotensin I to angiotensin II to lower blood pressure.
Pharmacology Practice Test
A comprehensive pharmacology exam covering drug mechanisms, antimicrobial agents, autonomic and central nervous system pharmacology, and pharmacodynamic principles for nursing and healthcare students preparing for NCLEX and clinical practice.
Exam Rules
- You can skip questions and return to them later
- Flag questions for review before submitting
- No feedback shown until you submit the entire exam
- Unanswered questions count as wrong — answer everything
- 10 pretest questions are mixed in and don't affect your score
- Timer auto-submits when time runs out
- Your progress is auto-saved every 30 seconds